VASOSTRICT (nda204485)- (20UNITS/100ML (0.2UNITS/ML),20UNITS/ML (20UNITS/ML),40UNITS/100ML (0.4UNITS/ML),50UNITS/50ML (1UNITS/ML),60UNITS/100ML (0.6UNITS/ML),200UNITS/10ML (20UNITS/ML))

Generic Name	VASOPRESSIN	Innovator	ENDO OPERATIONS
Dosage	20UNITS/100ML (0.2UNITS/ML),20UNITS/ML (20UNITS/ML),40UNITS/100ML (0.4UNITS/ML),50UNITS/50ML (1UNITS/ML),60UNITS/100ML (0.6UNITS/ML),200UNITS/10ML (20UNITS/ML)
ParaIV Filing	Yes	505(b)2 Filing	Yes
Last Patent Expiry	2035-Jan-30	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Vasostrict® is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
8	2	7

Other Developers

Total Other Developers	24

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
20UNITS/100ML (0.2UNITS/ML)	**	**	-	-	-
20UNITS/ML (20UNITS/ML)	**	**	-	-	-
40UNITS/100ML (0.4UNITS/ML)	**	**	-	-	-
50UNITS/50ML (1UNITS/ML)	**	**	-	-	-
60UNITS/100ML (0.6UNITS/ML)	**	**	-	-	-
200UNITS/10ML (20UNITS/ML)	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	5

Manufacturing Details of VASOSTRICT